Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) ("Cipher" or "the Company") today announced it has strengthened its product pipeline by acquiring the worldwide rights to three products from Astion ...
MISSISSAUGA, ON, May 15, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) today announced it has completed its previously announced strategic acquisition of the Canadian business portfolio of ...
Please provide your email address to receive an email when new articles are posted on . Cipher Pharmaceuticals announced it has acquired three products from Astion Pharma that are focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results